A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
 |
Wednesday, 7/19/2023 12:00 pm – 1:00 pm ET |
 |
Virtual event |
 |
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Tuesday, 7/25/2023 3:00 pm – 4:00 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Friday, 8/18/2023 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine in addiction treatment.
|
Tuesday, 8/22/2023 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS-funded STATE OBAT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Topic: Buprenorphine
This two-hour course will provide prescribers with the skills needed to implement addiction treatment in a practice setting. It is intended to provide prescribers with practical, evidence-based strategies for initiating and maintaining medications for opioid use disorder (MOUD) as well as tools to care for patients with ongoing use and/or polysubstance use.
|
Tuesday, 9/26/2023 12:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical professionals with prescriptive authority looking to increase provision of care for patients with opioid use disorder in an outpatient treatment setting or emergency department. |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.
|
Friday, 9/29/2023 10:00 am – 11:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Tuesday, 10/3/2023 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.
|
Thursday, 10/12/2023 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS-funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Topic: Buprenorphine
This two-hour course will provide prescribers with the skills needed to implement addiction treatment in a practice setting. It is intended to provide prescribers with practical, evidence-based strategies for initiating and maintaining medications for opioid use disorder (MOUD) as well as tools to care for patients with ongoing use and/or polysubstance use.
|
Wednesday, 10/25/2023 10:00 am – 12:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical professionals with prescriptive authority looking to increase provision of care for patients with opioid use disorder in an outpatient treatment setting or emergency department. |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.
|
Tuesday, 11/14/2023 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.